Health ❯ Obesity ❯ Treatment Options

Medications

Semaglutide Wegovy Oral Medications GLP-1 Drugs GLP-1 Agonists Tirzepatide Orforglipron Injections Clinical Research Generic Drugs GLP-1 Analogues Novo Nordisk Oral Therapies Oral Drugs Mounjaro Self-Pay Pharmacy GLP-1 Treatments Weight Loss Injections aGLP-1 Treatments Public Health GLP-1 Receptor Agonists Compounding Pharmacies Semaglutida FDA Approval Semaglutide and Tirzepatide

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Lilly’s premium price meets a new oral challenger in the GLP‑1 race.

Novo Nordisk Freezes Hiring as Layoffs Loom in GLP-1 Retrenchment

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition